Pacer Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.73M Buy
11,373
+8,804
+343% +$1.34M ﹤0.01% 1065
2025
Q1
$387K Sell
2,569
-1,517
-37% -$228K ﹤0.01% 1556
2024
Q4
$754K Sell
4,086
-1,281
-24% -$236K ﹤0.01% 1459
2024
Q3
$1.06M Buy
5,367
+252
+5% +$49.6K ﹤0.01% 1307
2024
Q2
$1.06M Buy
5,115
+1,604
+46% +$331K ﹤0.01% 1246
2024
Q1
$951K Buy
3,511
+94
+3% +$25.5K ﹤0.01% 1274
2023
Q4
$808K Sell
3,417
-3,669
-52% -$867K ﹤0.01% 1312
2023
Q3
$1.39M Buy
7,086
+902
+15% +$177K 0.01% 713
2023
Q2
$1.3M Buy
6,184
+2,417
+64% +$508K 0.01% 930
2023
Q1
$760K Buy
3,767
+3,586
+1,981% +$724K ﹤0.01% 1036
2022
Q4
$39.4K Sell
181
-43,458
-100% -$9.47M ﹤0.01% 2935
2022
Q3
$8.59M Buy
43,639
+40,889
+1,487% +$8.05M 0.06% 277
2022
Q2
$588K Buy
2,750
+109
+4% +$23.3K ﹤0.01% 656
2022
Q1
$750K Buy
2,641
+66
+3% +$18.7K 0.01% 1148
2021
Q4
$970K Sell
2,575
-1,561
-38% -$588K 0.01% 1222
2021
Q3
$1.71M Sell
4,136
-29
-0.7% -$12K 0.02% 707
2021
Q2
$1.54M Sell
4,165
-1,137
-21% -$421K 0.02% 685
2021
Q1
$1.54M Sell
5,302
-112
-2% -$32.5K 0.03% 600
2020
Q4
$1.35M Sell
5,414
-5,986
-53% -$1.5M 0.03% 570
2020
Q3
$2.58M Buy
+11,400
New +$2.58M 0.05% 321
2020
Q1
Sell
-16,591
Closed -$2.53M 765
2019
Q4
$2.53M Sell
16,591
-1,240
-7% -$189K 0.11% 191
2019
Q3
$2.36M Sell
17,831
-1,361
-7% -$180K 0.05% 415
2019
Q2
$2.72M Buy
+19,192
New +$2.72M 0.07% 339
2019
Q1
Sell
-173
Closed -$20K 749
2018
Q4
$20K Sell
173
-17,098
-99% -$1.98M ﹤0.01% 387
2018
Q3
$2.32M Buy
17,271
+2,112
+14% +$284K 0.09% 271
2018
Q2
$1.7M Buy
15,159
+2,034
+15% +$228K 0.08% 349
2018
Q1
$1.4M Buy
13,125
+1,941
+17% +$207K 0.08% 327
2017
Q4
$1.22M Buy
11,184
+3,948
+55% +$432K 0.09% 323
2017
Q3
$782K Buy
7,236
+958
+15% +$104K 0.07% 415
2017
Q2
$635K Buy
6,278
+667
+12% +$67.5K 0.06% 459
2017
Q1
$505K Buy
5,611
+1,015
+22% +$91.4K 0.06% 482
2016
Q4
$350K Buy
4,596
+317
+7% +$24.1K 0.05% 590
2016
Q3
$357K Buy
4,279
+360
+9% +$30K 0.05% 512
2016
Q2
$323K Buy
+3,919
New +$323K 0.05% 535